Graft-Versus-Host disease market Insights. DelveInsight's Graft-Versus-Host Disease Market report offers an in-depth understanding of the epidemiology and ...

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), will present at the 43rd Annual J.P. Morgan Healthcare ...

Hold Biocon 320-put option as stock may drop to ₹350, with potential for premium increase. Contact [email protected] ...

Biocon stock price has broken out from the upper band of a Symmetrical Triangle formation, indicating a positive movement.

Biocon Ltd has broken out of the Symmetrical Triangle formation on daily charts, suggesting a potential rise in stock price.

Nifty Pharma index ended down 0.94% at 23011.1 today. The index has gained 3.00% over last one month. Among the constituents, Lupin Ltd shed 4.47%, Biocon Ltd dropped 2.92% and Ipca Laboratories Ltd ...

Nifty 50, India’s benchmark index, closed 92 points higher on Tuesday, ending its two-day losing streak to settle at ...

Biocon Biologics completes one-year as an integrated global biosimilars enterprise: Our Bureau, Bengaluru Wednesday, January 8, 2025, 11:30 Hrs [IST] Biocon Biologics in its first ...

MUMBAI: Indian shares rose on Tuesday, led by a rally in energy stocks after a brokerage upgraded ONGC and as Reliance recovered some of its losses from the previous session. The Nifty 50 gained 0.39% ...

Microsoft CEO Satya Nadella announces a $3 billion investment in India's cloud and AI infrastructure, including new data ...

Biocon’s subsidiary, Biocon Biologics Limited (BBL), has announced the completion of its first year as a fully integrated ...

Biocon Biologics is committed to implementing business expansion in Malaysia. Biocon Biologics is a global company with ...